<h4>Background</h4>Recently, anti-programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) immunotherapy offers promising results for advanced biliary tract cancer (BTC). This evidence concerns the gene CD274 and biliary tract cancer.